At this time, posts about JW Pharmaceutical are rapidly increasing on portals and stock communities, while foreign investors are tentatively estimated to have net sold 39,088 shares today. JW Pharmaceutical is known as a leading pharmaceutical company in the industry famous for its infusion solutions.

As of 12:30 PM on the 11th, JW Pharmaceutical's stock price is 38,850 KRW, up 4.16% from the previous day, with a trading volume of 1,370,607 shares, which is 91.57% of the 5-day average trading volume. On August 6th, JW Pharmaceutical became a market issue with the news of the COVID-19 treatment effect of 'Nafamostat' causing a sharp rise.

In addition to JW Pharmaceutical, posts by investors are also rapidly increasing for LG Chem Preferred (051915), Teuksu Construction (026150), and Hanmi Science (008930).

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and financial AI specialist company Thinkpool.




This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing